Antihelminthic anthraquinones and method of use thereof
Anthraquinones are described which are antihelminthic and in particular, are useful in compositions for inhibiting Schistosoma sp. in vitro or in vivo. The preferred anthraquinones have the formula: wherein R 1 , R 2 , R 3 , and R 4 are each hydrogen, hydroxy, halogen, alkyl, substituted alkyl, alkene, substituted alkene, alkyne, aryl, substituted aryl, cyclic, substituted cyclic, acid group, carbohydrate, or combination thereof, R is a group containing 1 to 12 carbons such as methyl, alkyl, substituted alkyl, aldehyde, hydroxy, hydroxymethyl, acid group, carbohydrate, or combination thereof, and the halogen is I, F, Br, or Cl.
1. A method of inhibiting a parasitic helminth, which comprises:
exposing the helminth to an antihelminthic amount of at least one anthraquinone of the formula:
wherein R 1 , R 2 , R 3 , and R 4 are each selected from the group consisting of hydrogen, hydroxy, halogen, alkyl, acetyl alkene, alkene, alkyne, aryl, cyclic, acid group, carbohydrate, and combinations thereof, R is selected from the group consisting of methyl, alkyl, aldehyde, hydroxymethyl, acid group, and carbohydrate, each R containing 1 to 12 carbon atoms and the halogen is selected from the group consisting of I, F, Br, and Cl.
2. The method of claim 2 wherein the anthraquinone has the formula:
wherein R is a group containing 1 to 12 carbons selected from the group consisting of methyl alkyl, acetyl, aldehyde, hydroxymethyl, acid, and carbohydrate groups each containing 1 to 12 carbon atoms.
3. The method of claim 1 wherein the anthraquinone is 1,2,8-trihydroxy-3-methyl anthraquinone.
4. The method of claim 1 wherein the anthraquinone is 1,2,8-trihydroxy-3-hydroxymethyl anthraquinone.
5. The method of claim 1 wherein the inhibition is in vitro.
6. The method of claim 1 wherein the inhibition is in vivo.